Viewing StudyNCT00516217



Ignite Creation Date: 2024-05-05 @ 6:37 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00516217
Status: COMPLETED
Last Update Posted: 2016-07-06
First Post: 2007-08-14

Brief Title: Galiximab in Treating Patients With Relapsed or Refractory Hodgkins Lymphoma
Sponsor: Alliance for Clinical Trials in Oncology
Organization: Alliance for Clinical Trials in Oncology

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-06
Start Date Type: None
Primary Completion Date: 2011-09
Primary Completion Date Type: ACTUAL
Completion Date: 2015-02
Completion Date Type: ACTUAL
First Submit Date: 2007-08-14
First Submit QC Date: August 14 2007
Study First Post Date: 2007-08-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2015-02-04
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-07-01
Last Update Post Date: 2016-07-06
Last Update Post Date Type: ESTIMATED